The Cannabidiol (CBD) Conundrum: Understanding the Ingredient's Legal and Regulatory Status

Event Information
Product Format
Prerecorded Event
Presenter(s)
Length
60 minutes
Product Description

Learn to Evaluate And Mitigate the Risks Presented by CBD Business Opportunities


Now found in products as diverse as cosmetics, dietary supplements, pet treats, vape pens, and investigational pharmaceuticals, cannabidiol (CBD) has clearly captured the attention of consumers and industry. Manufacturers, marketers, retailers, and consumers have shown increased interest in products containing cannabidiol (CBD). However, much confusion remains about the federal legal and regulatory status of the ingredient, potential sources, and the various types of products in which companies include the ingredient.

Derived from cannabis, CBD has also generated equal amounts of controversy and confusion.  Chief among stakeholders’ concerns is the ingredient’s status under federal law. Federal regulators have staked out their positions, and industry groups have established their own.

This session by expert speaker Will Woodlee will frame the issues in plain language, helping you understand the merits and vulnerabilities of these competing positions, the factors that matter in determining the status of a particular CBD-containing product, and the issues that remain unsettled.

The session will also focus on explaining the key legal positions taken by the Food and Drug Administration and the Drug Enforcement Administration and their implications for the CBD market. You will be better informed to navigate the complex federal rules that determine the legal and regulatory status of CBD and various CBD-containing products. You will be better able to evaluate and mitigate the risks presented by certain CBD business opportunities. You will get risk-mitigation strategies for operating in the CBD industry, and understand the legal questions that remain unanswered and require continued monitoring.You will also gain the background needed to monitor and contextualize new developments in federal law, regulation, and policy impacting the CBD market.

Session Objectives

In this session, you will learn:

  • What cannabidiol is
  • If CBD “marijuana” is subject to DEA enforcement
  • What “industrial hemp” and the Farm Bill are and what they mean for potential marketers of CBD products
  • Whether the FDA regulates CBD too, and what restrictions and requirements might apply, and whether the product type matters
  • Whether the status of a CBD product under state law matters

Who Should Attend

  • Employees of manufacturers, distributors, and retailers of CBD products
  • Attorneys
  • Regulatory affairs specialists
  • Marketing professionals serving the industry
  • Investors
  • Entrepreneurs
  • Scientists
  • Government employees interested in learning more about regulation of the category

Order Below or Call 1-866-458-2965 Today

You can also order through:
Phone

1-866-458-2965

Fax

1-919-287-2643

About Our Speaker

Will Woodlee

Will Woodlee is a partner in the law firm of Kleinfeld, Kaplan, and Becker, LLP, in Washington, DC. His practice focuses primarily on counseling and advocating on behalf of food, dietary supplement, cosmetic, pharmaceutical, medical device, tobacco product, and consumer product companies on regulatory and advertising law matters. In 2015, Super Lawyers named Mr. Woodlee a "Rising Star" of the Washington, DC, metro area's “Food & Drugs” bar....   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus